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Abstract
Objective—Many adolescents with substance use problems show poor response to evidence
based treatments. Treatment outcome has been associated with individual differences in impulsive
decision making as reflected by delay discounting (DD) rates (preference for immediate rewards).
Adolescents with higher rates of DD were expected to show greater neural activation in brain
regions mediating impulsive/habitual behavioral choices and less activation in regions that
mediate reflective/executive behavioral choices.
Method—Thirty adolescents being treated for substance abuse completed a DD task optimized to
balance choices of immediate versus delayed rewards and a control condition accounted for
activation during magnitude valuation. A group independent component analysis on functional
magnetic resonance imaging (fMRI) time courses identified neural networks engaged during DD.
Network activity was correlated with individual differences in discounting rate.
Results—Higher discounting rates were associated with diminished engagement of an executive
attention control network involving the dorsolateral prefrontal cortex, dorsomedial prefrontal
cortex, inferior parietal cortex, cingulate cortex, and precuneus. Higher discounting rates were also
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associated with less deactivation in a “bottom up” reward valuation network involving the
amygdala, hippocampus, insula, and ventromedial prefrontal cortex. These 2 networks were
significantly negatively correlated.
Conclusions—Results support relations between competing executive and reward valuation
neural networks and temporal decision making, an important potentially modifiable risk factor
relevant for prevention and treatment of adolescent substance abuse.
Clinical trial registration information—The Neuroeconomics of Behavioral Therapies for
Adolescent Substance Abuse; http://clinicaltrials.gov/; NCT01093898.
Keywords
adolescent substance abuse; delay discounting; functional magnetic resonance imaging (fMRI);
neuroeconomics
Introduction
A primary model of decision making used to explain substance use behavior is intertemporal
decision making or choices between two alternatives that occur at different points in time.1
There is a general tendency for rewards to lose value the farther away they are in the future,
a phenomenon referred to as delay discounting. Delay discounting (DD) rates generally
follow a hyperbolic function, in which reward valuation decreases very rapidly across short
delays, and then more slowly across longer delays.2 DD is hypothesized to be particularly
relevant to substance use because substance use can be characterized as a choice between
the tangible and immediate rewards of consumption and the delayed rewards of abstinence.
There is a large literature supporting the association between DD rate and adult and
adolescent substance abuse onset and severity.1,3,4 Further, studies have reported worse
adult and adolescent substance abuse treatment outcomes for high discounters.5–7 For
example, we reported that treatment-enrolled teens with higher DD rates were less likely to
achieve abstinence.8
Neural Mechanisms of Delay Discounting
A meta-analysis9 identified 25 regions of significant neural activation during DD tasks.
Three primary regions of robust activation include value-related regions (ventral striatum),
value consideration regions (medial prefrontal cortex), and future forecasting regions
(posterior cingulate cortex). These regions are consistent with the valuation network
proposed by Peters and Buchel,10 who also propose 2 additional networks important in DD:
a cognitive control network, involving activation of the anterior cingulate cortex and
reduced top-down regulation of the medial prefrontal cortex (PFC) by the dorsolateral
prefrontal cortex, and a prospection/episodic imagery network, involving activity in the
medial temporal lobe (hippocampus and amygdala). However, there are developmental
differences between adolescent and adults in these regions that may impact DD. Adolescents
show maturation similar to adults in limbic and paralimbic “bottom up” brain regions that
function with respect to primary reinforcers;11,12 and slower maturation of the “top down”
frontal and prefrontal cortex, which regulate executive function and decision making.11,13
This asymmetric development is theorized to be related riskier decision making among
adolescents than adults.14,15 This combination of heightened neural response to reward and
motivational cues and delayed behavioral and cortical control may contribute to adolescent
preferences for immediate rewards.16
There are relatively few studies of neural mechanisms of DD in adolescence. Several studies
have examined age-related functional and structural brain changes related to DD, and 2 have
identified relations between neural function and structural connectivity and DD rates that
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were independent of age-related changes.17,18 For example, strengthening of functional
coupling among the ventromedial (VM) PFC, ventral striatum (VS), anterior cingulate
cortex (ACC), and the temporal lobe was associated with decreased discounting, suggesting
that developing connectivity between the VMPFC and VS systems may account for
individual differences in DD rates.17 Increased ventral PFC white matter organization is also
associated with decreased DD rates.18 These results suggest that there may be individual
brain and behavioral differences evident in adolescence that confer risk independent of
developmental changes.
Several studies have also documented neural structural and activation differences between
adolescent substance users and controls.19,20 There is longitudinal evidence that alcohol use
in adolescence may negatively impact both memory and attention,21 and evidence of neural
activation differences between substance users even at the earliest stages of tobacco use and
demographically matched same age peers.22 However, most informative for treatment
development is identifying the utility of individual neural differences among youth who
display problem use and/or who meet diagnostic criteria in predicting individual differences
in treatment relevant constructs such as decision making in order to ultimately improve
treatment outcomes.
The current study was designed to identify individual differences in neural network
activation related to decision making (DD) among adolescents with substance use problems.
Adolescent substance users were assessed at treatment entry using laboratory and fMRI
methods while making intertemporal choice decisions. Analyses explored relations between
the neural processing patterns that occur when making choices between immediate and
delayed rewards and DD rate. We hypothesized that the DD task would activate neural
networks consistent with reward valuation and cognitive control, and that the patterns of
activation in these networks would be correlated with individual differences in DD.
Method
Participants
Participants were recruited from 2 ongoing studies investigating behavioral treatments for
adolescent substance abuse (Marijuana Trial and Alcohol Trial). A total of 52 subjects
enrolled in the treatment studies during recruitment for the current study. Two teens refused
screening and 9 screened eligible but declined to participate in this study. A total of 6
subjects were not eligible for MRI due to metal in their body (most often braces), and 2
reported claustrophobia and were not scanned. In addition, data for 3 scanned subjects were
removed from the dataset due to head movement (n=1), incomplete discounting data (n=1),
and removal from scanner due to claustrophobia (n=1). A total of 30 scanned subjects were
included in the analyses. These participants were ages 12 to 18 (M age = 15.7; SD =1.7;
80% male; 63.3% Caucasian and 36.7% African American).
Teens in the Marijuana Trial (n=14) reported marijuana use in the past 30 days or provided a
tetrahydrocannabinol (THC)–positive urine test, plus met DSM criteria for marijuana abuse
or dependence. Teens in the Alcohol Trial (n=16) reported alcohol use in the past 30 days,
and either met DSM criteria for alcohol abuse or dependence or had had one binge episode
(≥5 drinks in one day) in the past 90 days. A bachelor’s level research assistant administered
the Vermont Structured Diagnostic Interview (VSDI23) to assess DSM-IV substance use and
mental health disorders. Interviewers were trained to administer the instruments via manual
review, observation, and supervised practice interviews. The interview has demonstrated
good psychometric properties.23 Binge drinking was assessed using the Time-Line Follow-
Back method24 for 90 days prior to intake. Alcohol-dependent youth were excluded from the
Marijuana Trial and were assigned to the Alcohol Trial. Youth eligible for both trials were
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assigned to the Alcohol Trial. Eighteen (60%) adolescents met criteria for marijuana abuse
or dependence only, 3 (10%) met criteria for alcohol abuse or dependence only, 6 (20%) met
criteria for marijuana abuse or dependence and alcohol abuse or dependence, and 3 (10%)
reported binge drinking only. On average, adolescents reported smoking marijuana on 9.40
days (SD = 9.66) and drinking alcohol on 1.87 days (SD = 2.97) in the 30 days prior to the
intake appointment. In addition, adolescents reported drinking an average of 3.29 (SD =
4.74, range = 0–16) drinks per drinking day in the 30 days prior to the intake appointment.
Based on caregiver and/or teen report, subjects also met criteria for one or more of these
disorders: attention-deficit/hyperactivity disorder (ADHD; caregiver: 36.7%, teen: 13.3%;
caregiver and/or teen: 36.7%), conduct disorder (caregiver:16.7%, teen: 6.7%; caregiver
and/or teen: 16.7%), oppositional defiant disorder (caregiver: 36.7%; teen: 16.7%; caregiver
and/or teen:43.3%), major depression (caregiver: 6.7%; teen: 13.3%; caregiver and/or teen:
16.7%), and generalized anxiety disorder (caregiver: 10.0%; teen: 13.3%; caregiver and/or
teen:16.7%). Tables S1 and S2, available online, provide individual and group level
demographic, DD, diagnostic, and substance use data.
Measurement of Delay Discounting
A delay discounting (DD) task was administered to each subject immediately prior to MRI
acquisition using a computerized program. Adolescents were asked to choose between
receiving a (hypothetical) $1,000 after a delay and receiving a smaller amount of money
immediately. For each delay, the subject was presented with six consecutive decision-
making trials. The delay intervals were one day, one week, one month, 6 months, one year, 5
years, and 25 years. For each delay, the amount of money offered “now” started at $500, and
the amount increased or decreased based on the subject’s choice for trials 2–6.
DD rate was estimated using Mazur’s2 equation: Vd = V / (1 + kD), where Vd represents the
discounted value at D delay, V is the undiscounted amount, and k is the estimated
discounting parameter. High values of k indicate greater discounting or preference for
immediate rewards. Vd was derived by calculating individuals’ indifference point, which is
the value of the immediate reward that is considered as attractive as the $1,000 delayed
reward. Indifference points were calculated for each delay and fit to the hyperbolic model of
DD rate (k) and then log transformed (lnk).
fMRI Procedures
Delay Discounting Task—The DD task completed in the scanner was optimized for
functional neuroimaging, using an event-related trial design. Functional T2*-weighted
echoplanar images (EPIs) were acquired using a Philips Achieva 3.0 Telsa X-series MRI
and an 8-channel head coil (Philips Healthcare, USA) with the following parameters: 3×3×3
mm3 isotropic voxels, repetition time (TR) = 2000 ms, echo time (TE) = 30 ms, field of
view (FOV) = 240mm×240mm, flip angle (FA) = 90°, matrix = 80×80, 37 slices. T1-
weighted structural images were acquired for alignment and tissue segmentation purposes
using an MPRAGE sequence (matrix=192×192, 160 slices, TR/TE/FA=2600 msec/3.02
msec/80, final resolution=1×1×1 mm3). In the scanner, the subject was presented with
discounting trials at each of 4 delay intervals (one month, 6 months, 1 year, and 5 years)
plus control trials (choice between 2 different amounts of money, both received “today”)
presented in a randomized sequence. The fMRI DD task used each individual’s indifference
points from the pre-MRI DD task as the starting value for the smaller, sooner (SS) amount at
each delay. This starting point was designed to produce equal numbers of SS and larger,
later (LL) choices at each delay, making the task similarly challenging for all subjects. The
smaller value was always offered “today” and presented on the left side of the screen and
$1,000 was offered at 1 of the delay intervals and displayed on the right. The subject made a
decision by pressing 1 of 2 buttons on a button box corresponding with their choice.
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Following the decision, the selected option was surrounded with a bold rectangle for one
second to confirm that a response was recorded. Choices involved the same delay intervals
and LL amount ($1,000) for all subjects, with variable SS amounts based on the subject’s
starting indifference point and subsequent choices at each delay.
The task was divided into two runs, each consisting of 2 sets of 25 trials and 3 sets of rest
periods (25 seconds), for a total of 100 decision making trials. The task was self-paced and
lasted approximately 20 minutes. Each set of 25 trials consisted of 5 trials of each of the four
delays and 5 control trials with a fixed interstimulus interval of 5 seconds. The subject’s
response on each trial of each delay determined whether or not the smaller amount offered
“today” on the next trial of that delay increased (prior selection of $1,000) or decreased
(prior selection of smaller amount) (algorithm available on request from first author).
Data Processing and Analyses—Image preprocessing and statistical analyses were
performed using Analysis of Functional Neuroimages (AFNI; afni.nimh.nih.gov) software.
Functional images underwent the following preprocessing steps: slice time correction,
deobliquing, motion correction, despiking, alignment to the subject’s structural image,
warping to Montreal Neurological Institute (MNI) standardized space, removal of signal
fluctuations in white matter and cerebral spinal fluid from voxel time courses, spatial
smoothing with a 6 mm full-width at half-maximum Gaussian kernel, scaling to percent
signal change, and, for voxel-wise contrasts, masking of non-gray matter voxels with masks
created using FSL software from the subject’s structural image.
Voxel-wise general linear model analyses were conducted in AFNI. Decision trials were
modeled as epochs beginning at the presentation of choices and ending with a response.
Participants’ mean response time ranged from 1.69 to 6.96 seconds (M=3.31, SD=1.16).
Neural activation associated with making 2 types of decisions, SS or LL, was compared to
that of control ‘no delay’ trials (CON) in voxel-wise contrasts. In addition, DD rate (lnk
value) was correlated with neural activity while making DD decisions in the scanner (i.e., SS
vs. CON; LL vs CON). Results from whole brain voxel-wise analyses were subjected to
multiple comparison correction based on 10,000 Monte-Carlo simulations conducted using
the 3dClustSim command in AFNI. To obtain a corrected p-value of 0.05, only clusters
composed of 17 or more voxels surviving a p-value threshold of 0.005 were considered
significant.
In addition, a group independent component analysis (ICA) on fMRI timecourses25 was
conducted with Group ICA of fMRI toolbox (GIFT) in Matlab,26 solving for 20
components. ICA was conducted with the infomax algorithm and the following selected
options: data entry (2 runs per subject), no dummy scans, using spatial temporal regression
for back-reconstruction, removal of image mean at each timepoint, standard PCA with
stacked datasets, 2-step data reduction, no batch estimation, and scaling values to z-scores.
ICA was repeated 5 times using the ICASSO algorithm to identify the most reliable and
stable components across all 5 ICA iterations.
For each subject, the experimental design was convolved with the SPM27 canonical
hemodynamic response function (HRF) to estimate the blood oxygenation level-dependent
(BOLD) signal response for 3 decision types: SS, LL, and CON. Estimated BOLD responses
for each trial type were modeled in regression analyses in GIFT as predictors of each
component time course, with 6 directions of head motion included as covariates. This
method is analogous to the general linear model approach to voxel-wise analysis of fMRI
task data, except that data were reduced from thousands of voxels to 20 independent
components. The association of each component with each trial type (SS, LL, and CON)
was represented by beta estimates and t-values. Thirteen components representing head
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motion, noise and sensory processing were excluded from further analysis. For the
remaining 7 components, contrast values were calculated for each subject for SS-CON trials
and LL-CON trials using beta estimates from the regression analysis. A positive contrast
value indicates that the network was more active during SS or LL than during CON trials,
and a negative contrast value indicates that the network was more active during CON than
SS or LL trials. Individual SS-CON and LL-CON contrast values for each of the 7 retained
components were correlated with lnk. Additional analyses controlled for age, sex, and past
30 day substance use (number of alcoholic drinks, number of days of marijuana and/or K2
(synthetic cannabis) use, and number of days of tobacco use). We hypothesized that
adolescents with substance abuse problems who have higher discounting rates, reflecting a
greater preference for immediate rewards, would show greater activation in neural regions
mediating impulsive/habitual behavioral choices and less activation in neural regions
mediating more reflective/executive behavioral choices compared to individuals exhibiting
lower rates of discounting.
Results
Localization of Whole Brain Activations Related to Intertemporal Choice Behavior
Pair-Wise Contrasts—Voxel-wise, brain-wide planned contrasts of SS-CON and LL-
CON choices resulted in distributed neural activations typically attributed to impulsive and
deliberative choice behavior. Task-related activations are reported in the Tables S3 and S4,
available online, and represent those that survived a cluster-level correction for multiple
comparisons.
Smaller/Sooner versus Control: Compared to the judgment of relative monetary amount in
the CON trials, the choice of SS rewards was associated with activation of dorsomedial,
dorsolateral and polar prefrontal cortex, precuneus, posterior cingulate cortex, fusiform and
lingual gyri, superior temporal gyrus, cerebellum, and paracentral lobule (Table S3,
available online). Relative to CON choices, SS choices were associated with less activation
of the inferior parietal cortex, right precentral gyrus extending into the inferior frontal
cortex, bilateral parahippocampal gyri, and temporal and parietal cortex.
Larger/Later versus Control: Compared to CON choices, the choice of LL rewards was
associated with activation of the pre-supplementary motor area (pre-SMA), polar and
dorsolateral prefrontal cortex, cuneus extending into the inferior occipital gyrus, cerebellum,
posterior cingulate cortex, bilateral dorsal caudate nucleus, and parietal cortex (Table S4,
available online). Choice of LL rewards relative to CON choices were associated with less
activation of the bilateral middle temporal gyrus, right inferior frontal cortex extending into
the amygdala, right dorsolateral prefrontal cortex, inferior parietal cortex, cuneus, middle
cingulate cortex, left inferior frontal cortex, and left amygdala.
Smaller/Sooner versus Larger/Later: Compared to the LL decision trials, SS choices were
associated with greater activation of the right lingual gyrus (7.5, −70.5, −6.5 mm) and
occipital cortex (34.5, −85.5, 17.5 mm). No other relative activations for LL versus SS trials
survived multiple comparison correction.
Regression Analyses—Brain-wide analyses assessed the relationship between
individual differences in discounting rate (lnk) and the magnitude of task-related regional
brain activation. Significantly correlated brain regions (p < 0.05, corrected) are reported in
Table S5, available online. For SS-CON, lnk was significantly correlated with activation of
the dorsomedial prefrontal cortex, bilateral middle/posterior insula, right posterior superior
temporal sulcus, precuneus, and posterior parietal cortex. For LL-CON, lnk was
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significantly correlated with activation of the bilateral middle insula, superior and middle
temporal gyri, dorsomedial prefrontal cortex, and precuneus. For SS-LL, no regions of
activation were significantly correlated with lnk following whole-brain correction.
Group ICA results
—Of the seven components of activation assessed in correlation analyses for their
relationship to individual differences in discounting rates, two components were
significantly correlated with lnk (p<0.05), though neither survived a Bonferroni correction
for the number of components tested (p<.05/[2 contrast types (SS vs. CON and LL vs. CON)
× 7 components=14]=.00357). Those 2 components are described below, and activation
patterns for the other 5 networks are shown in Figure S1, available online.
Valuation Network: As shown in Figure 1b, lnk positively correlated (r=0.45, p=0.013)
with relative activation for LL versus CON choices for a component comprising the
amygdala and hippocampus, paralimbic cortex involving the ventromedial prefrontal cortex,
insula and posterior cingulate cortex, and the ventral striatum (see Figure 1a). These
coactivated regions are involved in motivation, valuation, prospection, and salience
processing,10,28,29 suggesting that this component represents a valuation network. This
association remained after controlling for age, sex, and substance use frequency (r=0.56,
p=0.004).
Cognitive Control/Executive Function Network: As shown in Figure 2b, lnk negatively
correlated (r=−0.41, p=0.023) with activation for SS-CON choices in a bilateral frontal-
parietal network (right>left). Coactivated regions included the ventrolateral and dorsolateral
prefrontal cortex, superior parietal cortex, and precuneus (see Figure 2a). These regions are
involved in executive functions such as goal representation, cognitive control, and response
selection.10,30,31 This association remained after controlling for age, sex, and substance use
frequency (r=−0.44, p=0.029).
Network Correlations—To assess the role of functional network interactions in DD, the
correlation was computed between activity in these 2 networks during decision making trials
(mean activation during SS and LL choices). As shown in Figure 3, activity in these
networks was highly negatively correlated (r=−0.67, p<.0001), suggesting that the two
networks function in a reciprocal manner in contributing to individual differences in DD.
Discussion
Whole brain pairwise contrasts indicated extensive activations broadly consistent with many
other delay discounting fMRI studies.9 Group ICA yielded 7 components reflecting
theoretically consistent regions of neural coactivation during all trials. Activation in two
components or networks showed significant relations with individual DD rates. However,
neither effect survived the Bonferroni correction, supporting the need to replicate these
findings. One, a putative valuation network, showed ventral limbic activations involving the
amygdala and hippocampus, paralimbic cortex involving the ventromedial prefrontal cortex,
insula and posterior cingulate cortex, and the ventral striatum. These regions are involved in
multiple cognitive functions integral to intertemporal decision making, including valuation,
prospection/future forecasting, and episodic imagery.9,10 Others have reported similar
relations between ventral striatal activity and adolescent risk taking.32 These findings
uniquely demonstrate via ICA that these separate neural processes related to DD are
organized into a higher-order network. Further, activation of this higher-order network
predicted individual differences in DD rates. There was less activity among lower
discounters in this “bottom up” reward valuation network when choosing LL (compared to
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simple immediate reward magnitude valuation) and lesser suppression of activity among
higher discounters.
Activation in a network that likely reflects cognitive control and executive function was also
related to individual DD rates. Similar to the cognitive control, regulatory network proposed
by Peters and Buchel,10 this network showed bilateral frontal-parietal activations
encompassing the ventrolateral and dorsolateral prefrontal cortex, superior parietal cortex,
and precuneus. Higher DD teens show less engagement in this executive network than lower
DD teens during impulsive decision making, with SS choices reflecting less involvement of
this cognitive control network for higher discounters. In other words, SS choices involve
more executive processing for lower discounters.
The Group ICA results are consistent with 2 independent neural processing networks
mediating the valuation and choice processes related to DD with decreasing activation of a
frontal-parietal network and increasing activation of a limbic-paralimbic network both
predicting greater discounting. These results were consistent with a study showing that
higher risk taking on a gambling task was associated with reduced activity in control-related
regions in the dorsal medial PFC and greater activity in reward (valuation) regions in the
VMPFC among nonreferred adolescents.33 In the current study, similar relations were
observed between DD rate and activation in these regions in the dorsal medial PFC
(integrated into a larger cognitive control network) and in these regions in the VMPFC
(integrated into a larger valuation network).
The strong negative correlation observed between the 2 networks suggests that the balance
in activity between these networks influences temporal decision making. Several studies
have suggested that there are interacting (competing) networks involved in reward
valuation,34,35 with an evolutionarily older impulsive system (limbic and paralimbic
regions) primarily involved in the valuation of immediate rewards, and the more recently
developed executive system (prefrontal regions) involved in the consideration of the future
and the selection of delayed rewards. The balance (or imbalance) in activation and
connectivity between these competing valuation systems is hypothesized to underlie
individual DD rates.1 Alternatively, others have suggested that reward valuation is better
conceptualized as reflecting the activity of a single neural network that tracks subjective
value at all delays.36 Because we collapsed across all delays, we cannot specifically address
the role of delay in the activity of these networks. However, our results do support the
involvement of 2 distinct neural networks that function in opposition during temporal
decision making, with lower discounters showing greater activity in executive control
regions and greater suppression of activity in valuation regions.
The period of mid adolescence (ages 14–16) appears to be the time of greatest
developmental change in DD,15 suggesting that adolescence might be a unique and ideal
time to attempt to reduce DD. Interventions like contingency management that attempt to
shift preferences to delayed rewards might be most effective during this developmental
period. The use of rewards may also influence decision making and its neural correlates
among adolescent substance users. For example, adolescents with substance use problems
have shown greater activation than control adolescents in prefrontal cognitive control
regions an inhibition task when rewards were available.37 Similarly, the use of rewards
facilitates cognitive control among adolescents to a greater extent than for adults.38 Thus,
treatment approaches that offer consistent and tangible rewards might be particularly
effective in adolescence, and the mechanism for such enhanced effects might be enhanced
engagement of cognitive control or executive brain regions related to DD.
Stanger et al. Page 8













Working memory training may also influence neural function related to DD leading to
reductions in substance use. For example, individual differences in DD among healthy
adults are correlated with activity in the left anterior prefrontal cortex while performing a
working memory task.39 Further, Bickel et al.40 showed that working memory training
resulted in reductions in DD rates among adult stimulant abusers. Similarly, Houben et al.41
showed working memory training led to significant reductions in alcohol intake among
problem drinkers. These results suggest that interventions involving working memory
training might enhance treatment response by influencing the activity or functional balance
of neural networks that underlie DD.
Overall, this study was intended as an initial exploratory study, and these results should be
considered preliminary until they are replicated with a larger, independent sample. Beyond
the tested variables of age, sex, and recent substance use frequency, the sample was
heterogeneous for other substance use and/or mental health history and problems, which
may have influenced the findings. Overall, the sample size precluded a cross-sectional
assessment of developmental changes in these networks or in DD. It was also unable to
control exposure to specific substances in specific quantities. This study tested individual
differences among substance users entering treatment. It will be important in future studies
to assess the generalizability of these networks to teens who do not use substances, teens
with substance use problems but not seeking treatment, and similar samples of adults. There
are also differing methods and fMRI task parameters that have been used to study DD which
may contribute to differences in activation across studies. For example, ensuring
comparability in decision difficulty across subjects and balancing frequency of SS and LL
choices may maximize relations between behavioral measures and neural activity42, but may
minimize differences in neural activity for SS vs. LL.
Delay discounting is related to many forms of substance abuse, and it may be an informative
marker of individual differences that could predict treatment response and/or improve as a
result of treatment. Two neural processing networks were found to relate to individual
differences in DD rates. These bottom up (e.g., limbic and paralimbic) and top down (e.g.,
parietal and prefrontal) networks functioned in opposition while subjects made temporal
decisions about rewards. Developmental differences in the maturation of these networks
may make teens both more vulnerable to impulsive decision making and substance use and
more responsive to interventions targeting these systems. Neuroeconomic approaches can
contribute to the understanding of neural mechanisms that underlie DD behavior, and
thereby may offer additional clues to better direct prevention or treatment approaches. These
results showing discounting-related differences in neural activation are consistent with
competing neurobehavioral decision systems theory. Interventions to modify DD and its
underlying neural mechanisms including those targeting working memory might lead to
enhanced treatment outcome among adolescent substance users.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Valuation network: larger, later (LL) choice trials versus control trials. Note: (A) Network
map: Depicted regions were coactivated by task, as identified from group independent
component analysis of functional magnetic resonance imaging time course. (B) Correlation
between log-transformed delay discounting rate (lnk) and network activation. Individual
contrast values for LL versus control trials (positive value indicates greater activity for LL
versus control; negative value indicates less activity for LL versus control) are on the y axis;
individual values of lnk are on the x axis.
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Cognitive control/executive function network: smaller, sooner (SS) choice trials versus
control trials. Note: (A) Network map. A second network of coactivated brain regions as
determined from group independent component analysis of functional neuroimaging time
courses. (B) Correlation between log-transformed delay discounting rate (lnk) and network
activation. Individual contrast values for SS versus control trials (positive value indicates
greater activity for SS versus control; negative value indicates less activity for SS versus
control) are on the y axis; individual values of lnk are on the x axis.
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Correlation between valuation and cognitive control networks. Note: Individuals’ mean
brain activity for the cognitive control network (x-axis) plotted against mean brain activity
for the valuation network (y-axis) for all decision making trials (irrespective of choice)
versus control trials.
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